HOME Research Insight Boston Scientific Corporation (US) and Cook Group Incorporated (US) are the Major Player in the Gastrointestinal / GI Stent Market



Boston Scientific Corporation (US) and Cook Group Incorporated (US) are the Major Player in the Gastrointestinal / GI Stent Market


The global gastrointestinal stents market is projected to reach USD 452.6 Million by 2022 from USD 353.4 Million in 2017, at a CAGR of 5.1% from 2017 to 2022. Growth in the geriatric population, increasing preference for minimally invasive surgeries, and rising prevalence of GI cancers and other digestive diseases are the major factors driving the growth of the gastrointestinal stents market. The development of biodegradable and drug-eluting gastrointestinal stents and emerging markets are also expected to offer growth opportunities for players seeking to venture into the gastrointestinal stents market.

The global gastrointestinal stents market is consolidated at the top with the presence of a few big players; however, there are many local, regional, and global players as well operating in the market. Boston Scientific (US), Cook Group (US), Micro-Tech (China), Taewoong Medical (South Korea), and ELLA-CS (Czech Republic) are the major players in this market. These companies mainly focus on the strategies of acquisitions, product launches, and expansions in order to remain competitive and further increase their share in the market.

Boston Scientific Corporation (US) dominated the global gastrointestinal stents market in 2016. The company focuses on increasing its share in the market by strategically investing in R&D activities. For instance, in 2016, the company invested USD 920 Million in R&D, as compared to USD 876 Million in 2015. The company’s focus on improving its speed and performance through new capabilities, processes, and advanced innovative technologies; its expanding commercial presence globally; and its cost-reduction initiatives help it to sustain its dominant position in the market. In 2016, the company’s revenue reported a growth of 12% as compared to the previous year. The company is also focusing on expanding its business in emerging countries. It reported a growth of 22% in its annual revenue in China, which is one of the largest emerging markets in the developing world.

Cook Group Incorporated (US) is also a major player in the gastrointestinal stents market. The company offers a wide range of gastrointestinal stent products for biliary, pancreatic, duodenal, and esophageal applications. With Evolution (esophageal stents), the company provides precision deployment or recapture of stents. The plastic stent portfolio offered by the company provides various file features such as the ease of loading & introduction into the ductal system, enhanced drainage, and fluoroscopic visualization.

Related Reports:

Gastrointestinal / GI Stent Market by Type (Biliary, Esophageal, Colonic, Pancreatic Stent) Material (Nitinol, Stainless Steel, Plastic) Disease (Biliary Disease, GI Cancer, IBD), End User (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022

Contact:
Mr. Rohan
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA : 1-888-600-6441 
sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports